)
Edge29 May 2026
Who You Gonna Call? The Story of Rollins
How Rollins built one of America's most consistent businesses through recurring pest control, trusted local brands, and decades of acquisitions.
Shanghai Allist Pharmaceuticals
Shanghai Allist Pharmaceuticals (688578) investor relations material
Shanghai Allist Pharmaceuticals Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 2026 earnings summary22 Apr, 2026
Executive summary
Achieved revenue of RMB 1.58 billion in Q1 2026, up 44.19% year-over-year, driven by strong sales of three key oncology drugs following inclusion in the national medical insurance directory.
Net profit attributable to shareholders reached RMB 636 million, a 54.94% increase year-over-year.
Continued focus on innovation and R&D in oncology, with expanded patient coverage and product approvals.
Financial highlights
Operating income: RMB 1.58 billion, up 44.19% year-over-year.
Net profit attributable to shareholders: RMB 636 million, up 54.94% year-over-year.
Operating cash flow: RMB 554 million, up 41.06% year-over-year.
Basic and diluted EPS: RMB 1.41, up 54.94% year-over-year.
R&D investment: RMB 128 million, up 14.09% year-over-year, representing 8.08% of revenue.
Outlook and guidance
Plans to further strengthen commercialization and academic promotion of oncology products.
Aims to leverage differentiated product advantages and expand patient benefit.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Shanghai Allist Pharmaceuticals
- H1 2024 revenue and profit surged over 100% YoY, led by core product sales and cost control.688578
Q2 20244 Jun 2026 - Revenue and profit surged on Furmonertinib sales; R&D and pipeline expansion accelerated.688578Q4 20244 Jun 2026
- Q3 revenue and net profit more than doubled year-over-year, fueled by strong oncology sales.688578Q3 20244 Jun 2026
- Revenue up 47.86% and net profit up 34.13% year-over-year, led by oncology drug growth.688578Q1 20254 Jun 2026
- RMB 0.40 per share cash dividend to be paid September 10, 2025, totaling RMB 180 million.688578Q2 20254 Jun 2026
- Net profit surged 53.1% to ¥2.19 billion on 45.8% revenue growth, with robust oncology sales.688578Q4 20254 Jun 2026
- Revenue and net profit soared on core drug sales, with new approvals set to drive future growth.688578Q3 20254 Jun 2026
Next Shanghai Allist Pharmaceuticals earnings date
Q2 202621 Aug, 2026
Shanghai Allist Pharmaceuticals
Next Shanghai Allist Pharmaceuticals earnings date
Q2 202621 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage